Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Verrica Pharmaceuticals Inc. (VRCA) is a Biotechnology company based in US with a market capitalization of $57.9M. Revenue grew 370.2% year-over-year and free cash flow was negative at -$17.6M. This page tracks VRCA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 71 employees · IPO Jun 15, 2018
Valuation
Valuation & price
$6.27as of May 17, 2026· -31.1% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
2.34
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$57.9M
Market cap
370.2%
Revenue growth (YoY)
90.3%
Gross margin
-$17.6M
Free cash flow (USD)
-$28.5M
Net debt
Net cash position
105.6%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 12, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Verrica Pharmaceuticals Inc.'s market cap?
Verrica Pharmaceuticals Inc. (VRCA) has a market capitalization of $57.9M.
What is VRCA's P/E ratio?
A meaningful P/E ratio is not available for VRCA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is VRCA's price-to-book (P/B) ratio?
VRCA trades at 2.34 times book value per share.
Are insiders buying VRCA stock?
SEC Form 4 filings show no open-market insider buys at Verrica Pharmaceuticals Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.